{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T17:35:24Z","timestamp":1773423324567,"version":"3.50.1"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T00:00:00Z","timestamp":1767312000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"\n Background<\/jats:title>\n Pertussis remains a significant threat to infants, particularly in settings like China, where maternal tetanus-diphtheria-acellular pertussis (Tdap) vaccination is not part of the National Immunization Program, and data on maternal pertussis immunity are limited. This study aimed to assess the seroprevalence of protective pertussis toxin (PT) IgG antibodies in pregnant women and quantify the potential risk of infant pertussis under varying epidemiological scenarios.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n \n A cross-sectional serosurvey was conducted among 1,205 pregnant women in Jiangsu Province, China, from January to December 2024. Serum anti-PT IgG concentrations were measured using ELISA, with a protective threshold defined as \u226540 IU\/mL. A scenario-based risk model (\n \n P\n infant<\/jats:sub>\n <\/jats:italic>\n =(1\u2212\n \n p\n m<\/jats:sub>\n <\/jats:italic>\n )\u00d7\n \n I\n w<\/jats:sub>\n <\/jats:italic>\n \u00d7\n E<\/jats:italic>\n \u00d7\n T<\/jats:italic>\n ) was developed to estimate infant pertussis risk (0\u20136 months) by linking maternal protection proportion (\n \n p\n m<\/jats:sub>\n <\/jats:italic>\n ), age-specific incidence in childbearing-age women\n \n I\n w<\/jats:sub>\n <\/jats:italic>\n ), exposure window (\n E<\/jats:italic>\n ), and mother-to-infant transmission probability (\n T<\/jats:italic>\n ).\n <\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n The overall median anti-PT IgG concentration was 6.34 IU\/mL (IQR: 4.24\u201311.16), with only 3.57% (95% CI: 2.66\u20134.77%) of women achieving the protective threshold (\u226540 IU\/mL). Under a representative scenario (\n \n I\n w<\/jats:sub>\n <\/jats:italic>\n = 50\/100,000,\n T<\/jats:italic>\n = 0.20), the model estimated 4.82 infant cases per 100,000 births under current immunity, reduced to 1.00 cases with maternal Tdap (\n \n p\n m<\/jats:sub>\n <\/jats:italic>\n = 80.0%), a 79.2% relative reduction. Higher incidence and transmission scenarios yielded greater absolute reductions with vaccination.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusion<\/jats:title>\n Low maternal pertussis immunity in China poses a quantifiable risk to infants, particularly under elevated incidence scenarios. Maternal Tdap vaccination could substantially reduce infant pertussis burden, supporting its consideration for national immunization policy. These findings provide critical evidence for addressing immunity gaps and protecting vulnerable newborns in China.<\/jats:p>\n <\/jats:sec>","DOI":"10.3389\/fimmu.2025.1687663","type":"journal-article","created":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T06:28:17Z","timestamp":1767335297000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Low maternal pertussis protection and quantified infant risk: supporting maternal Tdap vaccination in China"],"prefix":"10.3389","volume":"16","author":[{"given":"Wen","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tingting","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pop.2018.05.003","article-title":"Pertussis: the whooping cough","volume":"45","author":"Nguyen","year":"2018","journal-title":"Prim Care"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2024.106289","article-title":"Global resurgence of pertussis: A perspective from China","volume":"89","author":"Liu","year":"2024","journal-title":"J Infect"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp1209051","article-title":"Epidemic pertussis in 2012\u2013the resurgence of a vaccine-preventable disease","volume":"367","author":"Cherry","year":"2012","journal-title":"N Engl J Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2015.10.136","article-title":"Pertussis vaccines: WHO position paper, August 2015\u2013Recommendations","volume":"34","year":"2016","journal-title":"Vaccine"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2024.2389086","article-title":"Rising pertussis cases and deaths in China: current trends and clinical solutions","volume":"13","author":"Yahong","year":"2024","journal-title":"Emerg Microbes Infect"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.160193","article-title":"Effectiveness of pertussis vaccination and duration of immunity","volume":"188","author":"Schwartz","year":"2016","journal-title":"Cmaj"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a029454","article-title":"What is wrong with pertussis vaccine immunity? The problem of waning effectiveness of pertussis vaccines","volume":"9","author":"Burdin","year":"2017","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2021.04.032","article-title":"Pertussis vaccine effectiveness and duration of protection - A systematic review and meta-analysis","volume":"39","author":"Wilkinson","year":"2021","journal-title":"Vaccine"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1017\/S095026881400260X","article-title":"Epidemiological features of pertussis resurgence based on community populations with high vaccination coverage in China","volume":"143","author":"Huang","year":"2015","journal-title":"Epidemiol Infect"},{"key":"B10","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.jinf.2016.04.004","article-title":"Seroprevalence of pertussis among adults in China where whole cell vaccines have been used for 50 years","volume":"73","author":"Chen","year":"2016","journal-title":"J Infect"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1186\/s12879-021-06732-1","article-title":"Mortality risk factors among hospitalized children with severe pertussis","volume":"21","author":"Shi","year":"2021","journal-title":"BMC Infect Dis"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2018.14298","article-title":"Association between third-trimester Tdap immunization and neonatal pertussis antibody concentration","volume":"320","author":"Healy","year":"2018","journal-title":"JAMA"},{"key":"B13","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1001\/jamapediatrics.2022.5689","article-title":"US infant pertussis incidence trends before and after implementation of the maternal tetanus, diphtheria, and pertussis vaccine","volume":"177","author":"Skoff","year":"2023","journal-title":"JAMA Pediatr"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/cei.13275","article-title":"Antibody responses to Bordetella pertussis and other childhood vaccines in infants born to mothers who received pertussis vaccine in pregnancy - a prospective, observational cohort study from the United Kingdom","volume":"197","author":"Rice","year":"2019","journal-title":"Clin Exp Immunol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu821","article-title":"A case-control study to estimate the effectiveness of maternal pertussis vaccination in protecting newborn infants in England and Wales, 2012-2013","volume":"60","author":"Dabrera","year":"2015","journal-title":"Clin Infect Dis"},{"key":"B16","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1186\/s12887-019-1860-5","article-title":"The maternal antibody against diphtheria, tetanus and pertussis showed distinct regional difference in China","volume":"19","author":"Meng","year":"2019","journal-title":"BMC Pediatr"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-010-1104-y","article-title":"What to do and what not to do in serological diagnosis of pertussis: recommendations from EU reference laboratories","volume":"30","author":"Guiso","year":"2011","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"B18","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1038\/s41467-024-44943-7","article-title":"Maternal pertussis immunization and the blunting of routine vaccine effectiveness: a meta-analysis and modeling study","volume":"15","author":"Briga","year":"2024","journal-title":"Nat Commun"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwg251","article-title":"The interval between successive cases of an infectious disease","volume":"158","author":"Fine","year":"2003","journal-title":"Am J Epidemiol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a112560","article-title":"Airborne spread of measles in a suburban elementary school","volume":"107","author":"Riley","year":"1978","journal-title":"Am J Epidemiol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1097\/EDE.0b013e31826c2b9e","article-title":"Estimation of household transmission rates of pertussis and the effect of cocooning vaccination strategies on infant pertussis","volume":"23","author":"de Greeff","year":"2012","journal-title":"Epidemiology"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1097\/01.inf.0000160914.59160.41","article-title":"Duration of immunity against pertussis after natural infection or vaccination","volume":"24","author":"Wendelboe","year":"2005","journal-title":"Pediatr Infect Dis J"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cis923","article-title":"Importance of timing of maternal combined tetanus, diphtheria, and acellular pertussis (Tdap) immunization and protection of young infants","volume":"56","author":"Healy","year":"2013","journal-title":"Clin Infect Dis"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofae655","article-title":"Impact of the US maternal tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccination program on preventing pertussis in infants 2 to <6 months of age: A case-control evaluation","volume":"11","author":"Skoff","year":"2024","journal-title":"Open Forum Infect Dis"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)60686-3","article-title":"Effectiveness of maternal pertussis vaccination in England: an observational study","volume":"384","author":"Amirthalingam","year":"2014","journal-title":"Lancet"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2015-1120","article-title":"Sources of infant pertussis infection in the United States","volume":"136","author":"Skoff","year":"2015","journal-title":"Pediatrics"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6840e1","article-title":"Vital signs: burden and prevention of influenza and pertussis among pregnant women and infants - United States","volume":"68","author":"Lindley","year":"2019","journal-title":"Mmwr Morb Mortal Wkly Rep"},{"key":"B28","doi-asserted-by":"publisher","first-page":"e1207","DOI":"10.1016\/j.heliyon.2019.e01207","article-title":"Effectiveness of dTpa vaccination during pregnancy in preventing whooping cough in infants under 3 months of age. Bizkaia, Basque Country, Spain","volume":"5","author":"Uriarte","year":"2019","journal-title":"Heliyon"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2025.2473328","article-title":"How to improve pertussis vaccination in pregnancy: a European expert review","volume":"24","author":"Finn","year":"2025","journal-title":"Expert Rev Vaccines"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofaf154","article-title":"Country-specific data and priorities for pertussis in Latin America: recent findings from the global pertussis initiative","volume":"12","author":"Ulloa-Gutierrez","year":"2025","journal-title":"Open Forum Infect Dis"},{"key":"B31","unstructured":"China\u2019s newborns rise in 2024\n \n \n 2025"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1071\/HC17040","article-title":"Factors influencing women\u2019s decisions about having the pertussis-containing vaccine during pregnancy","volume":"10","author":"Hill","year":"2018","journal-title":"J Prim Health Care"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2015-3326","article-title":"Waning Tdap effectiveness in adolescents","volume":"137","author":"Klein","year":"2016","journal-title":"Pediatrics"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2010.11.024","article-title":"Maternal immunization with tetanus-diphtheria-pertussis vaccine: effect on maternal and neonatal serum antibody levels","volume":"204","author":"Gall","year":"2011","journal-title":"Am J Obstet Gynecol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1687663\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T06:28:18Z","timestamp":1767335298000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1687663\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,2]]},"references-count":34,"alternative-id":["10.3389\/fimmu.2025.1687663"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1687663","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,2]]},"article-number":"1687663"}}